Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Statements of Cash Flows (Unaudited)

v3.22.2.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities    
Net loss $ (26,584) $ (57,146)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Impairment of other long-lived assets 3,865 1,944
Depreciation and amortization 44,451 41,412
Stock-based compensation 24,755 23,140
Foreign currency transaction loss 13,978 4,210
Gain from deconsolidation of subsidiary (39,136)
Share in loss of associated companies 2,089 (1,229)
Revaluation of investments 3,217 556
Other non-cash items, net 826 364
Change in cash attributable to changes in operating assets and liabilities:    
Accounts receivable, net (21,832) (17,023)
Inventories (64,286) 8,271
Other current assets and prepaid expenses 3,898 (11,911)
Other non-current assets (17,003) 3,834
Accounts payable 17,286 29,204
Other current liabilities 2,013 14,047
Deferred revenues 4,860 3,470
Deferred income taxes, net and uncertain tax positions (301) (6,677)
Other non-current liabilities (9,385) (5,070)
Net cash provided by (used in) operating activities (57,289) 31,396
Cash flows from investing activities    
Cash paid for acquisitions, net of cash acquired (6,669)
Purchase of property and equipment (11,761) (16,193)
Investments in short-term bank deposits (307,485) (249,000)
Proceeds from short-term bank deposits 368,429 89,000
Purchase of intangible assets (5,980) (1,219)
Other investing activities 84 (85)
Investments in unconsolidated entities (67,274) (7,000)
Net cash used in investing activities (23,987) (191,166)
Cash flows from financing activities    
Proceeds from public offering, net of issuance costs 218,850
Proceeds from exercise of stock options 260 3,699
Payment of contingent consideration (1,386)
Other financing activities (281) 406
Net cash provided by (used in) financing activities (1,407) 222,955
Effect of exchange rate changes on cash, cash equivalents and restricted cash (9,787) (2,413)
Net change in cash, cash equivalents and restricted cash (92,470) 60,772
Cash, cash equivalents and restricted cash, beginning of period 243,293 272,216
Cash, cash equivalents and restricted cash, end of period 150,823 332,988
Supplemental disclosures of cash flow information:    
Transfer of inventory to fixed assets 6,306 2,760
Transfer of fixed assets to inventory 123 844
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:    
Cash and cash equivalents 150,672 332,871
Restricted cash included in other current assets 151 117
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows $ 150,823 $ 332,988